Ozone Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 7.50 Cr
- Paid Up Capital ₹ 5.54 Cr
- Company Age 33 Year, 10 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 87.86 Cr
- Satisfied Charges ₹ 59.22 Cr
- Revenue Growth 12.80%
- Profit Growth -69.73%
- Ebitda -22.94%
- Net Worth 1.65%
- Total Assets 5.47%
About Ozone Pharmaceuticals
Ozone Pharmaceuticals Limited (OPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 13 March 1991 and has a history of 33 years and ten months. Its registered office is in Delhi, India.
The Corporate was formerly known as Ozone Pharmaceuticals Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 7.50 Cr and a paid-up capital of Rs 5.54 Cr.
The company currently has active open charges totaling ₹87.86 Cr. The company has closed loans amounting to ₹59.22 Cr, as per Ministry of Corporate Affairs (MCA) records.
Vinod Kapur, Akarsh Kashyap, Subhash Sehgal, and Five other members serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U99999DL1991PLC043461
- Company No.
043461
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
13 Mar 1991
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Ozone Pharmaceuticals Limited offer?
Ozone Pharmaceuticals Limited offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Vitamin Tablets & Capsules, Digestive System Drugs & Medicines, Gastrointestinal Drugs, Face Wash, Ozone Face Wash, Cough Syrup, Pharmaceutical Syrup, Oral Suspension, Methylcobalamin Tablets.
Who are the key members and board of directors at Ozone Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Subhash Sehgal  | Managing Director | 21-Jun-1996 | Current |
Board Members (7)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Vinod Kapur | Director | 14-Sep-2020 | Current |
| Geeta Sehgal | Director | 30-Dec-2009 | Current |
| Dipak Singh | Director | 01-Feb-2016 | Current |
| Akarsh Kashyap | Director | 19-Oct-2015 | Current |
| Neelam Oberoi | Director | 01-Jun-2021 | Current |
| Anupam Verma | Whole-Time Director | 10-Mar-2015 | Current |
Financial Performance of Ozone Pharmaceuticals.
Ozone Pharmaceuticals Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 12.8% increase. The company also saw a substantial fall in profitability, with a 69.73% decrease in profit. The company's net worth moved up by a moderate rise of 1.65%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Ozone Pharmaceuticals?
In 2023, Ozone Pharmaceuticals had a promoter holding of 93.30% and a public holding of 6.70%. The company had 2 Subsidiaries and 2 Associate Companies. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kryton Buildmat Company Private LimitedVinod Kapur is a mutual person
North East Mega Food Park LimitedAkarsh Kashyap, Subhash Sehgal and 1 more are mutual person
Rrr Insolvency Service Experts LlpAkarsh Kashyap is a mutual person
- Rrr Restructuring & Resolution Advisory Llp
Akarsh Kashyap is a mutual person
- Blip Initiatives Llp
Subhash Sehgal is a mutual person
- Assam Agrotech Private Limited
Subhash Sehgal and Dipak Singh are mutual person
Charges (Loans)
₹87.86 Cr
₹59.22 Cr
Charges Breakdown by Lending Institutions
- Hdfc Bank Limited : 33.95 Cr
- Yes Bank Limited : 26.92 Cr
- Others : 18.46 Cr
- Icici Bank Limited : 7.54 Cr
- Axis Bank Limited : 0.98 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 14 Jun 2024 | Hdfc Bank Limited | ₹3.10 M | Open |
| 08 Feb 2024 | Hdfc Bank Limited | ₹1.29 Cr | Open |
| 29 Nov 2023 | Axis Bank Limited | ₹7.65 M | Open |
| 04 Sep 2023 | Yes Bank Limited | ₹1.92 Cr | Open |
| 04 Sep 2023 | Yes Bank Limited | ₹25.00 Cr | Open |
How Many Employees Work at Ozone Pharmaceuticals?
Ozone Pharmaceuticals has a workforce of 1992 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Ozone Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ozone Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
